Description: Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey. It offers microbiology, genetic disorder, panel, sequencing, and food testing kits; and manual spin column and magnetic bead nucleic acid extraction kits, and automated NA extraction instrument kits. The company provides products for diseases, such as brucellosis, chlamydia trachomatis, cytomegalovirus, crimean-congo hemorrhagic fever, novel coronavirus (2019-NCoV)/SARS-CoV-2, epstein-barr virus, hepatitis B, hepatitis C, hepatitis D, herpes simplex virus, human immunodeficiency virus, human papillomavirus, JC and BK polyomaviruses, malaria, measles, meningitis, respiratory infection, parvovirus B19, torque teno virus, toxoplasmosis, tuberculosis, ureaplasma, and west nile virus diseases, as well as factor II, factor V leiden, and methylene-tetra-hydro-folate-reductase mutation diseases. Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. is headquartered in Istanbul, Turkey.
Home Page: www.anatoliageneworks.com
Hasanpasa Mah.
Istanbul,
34920
Turkey
Phone:
90 216 330 04 55
Officers
| Name | Title |
|---|---|
| Alper Akyuz | Chairman of Management Board |
| Elif Akyuz | Vice Chairman of Management Board |
Exchange: IS
Country: TR
Currency: Turkish lira (₺)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 7.2385 |
| Price-to-Book MRQ: | 6.4237 |
| Price-to-Sales TTM: | 14.5622 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 163 |